These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21827011)

  • 1. [Adherent culture of CD133+ cells in glioblastomas and expression of ADLH1].
    Wang P; Mao Q; Wang X; Chen MN; Gan LA; Liu YH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):413-6. PubMed ID: 21827011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes.
    Roudi R; Korourian A; Shariftabrizi A; Madjd Z
    Cancer Invest; 2015; 33(7):294-302. PubMed ID: 26046383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CD133(+) Colo205 colorectal cancer cells express high levels of ALDH1 in serum-free culture].
    Li L; Zhang S; Liang F; Lin Y; Li R; Chen C; Xiao B
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):889-93. PubMed ID: 23803205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
    Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
    Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates].
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):147-51. PubMed ID: 23016266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Significance of CD133 and ALDH1 Cancer Stem Cell Marker Expression in Invasive Ductal Breast Carcinoma.
    Mansour SF; Atwa MM
    Asian Pac J Cancer Prev; 2015; 16(17):7491-6. PubMed ID: 26625750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plastic induction of CD133AC133-positive cells in the microenvironment of glioblastoma spheroids.
    Ohnishi K; Tani T; Bando S; Kubota N; Fujii Y; Hatano O; Harada H
    Int J Oncol; 2014 Aug; 45(2):581-6. PubMed ID: 24897999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.
    Beier D; Hau P; Proescholdt M; Lohmeier A; Wischhusen J; Oefner PJ; Aigner L; Brawanski A; Bogdahn U; Beier CP
    Cancer Res; 2007 May; 67(9):4010-5. PubMed ID: 17483311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro.
    Mihatsch J; Toulany M; Bareiss PM; Grimm S; Lengerke C; Kehlbach R; Rodemann HP
    Radiother Oncol; 2011 Jun; 99(3):300-6. PubMed ID: 21704411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia upregulates aldehyde dehydrogenase isoform 1 (ALDH1) expression and induces functional stem cell characteristics in human glioblastoma cells.
    Soehngen E; Schaefer A; Koeritzer J; Huelsmeyer V; Zimmer C; Ringel F; Gempt J; Schlegel J
    Brain Tumor Pathol; 2014 Oct; 31(4):247-56. PubMed ID: 24197864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133 is essential for glioblastoma stem cell maintenance.
    Brescia P; Ortensi B; Fornasari L; Levi D; Broggi G; Pelicci G
    Stem Cells; 2013 May; 31(5):857-69. PubMed ID: 23307586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
    Shin JH; Lee YS; Hong YK; Kang CS
    J Neurooncol; 2013 Dec; 115(3):333-41. PubMed ID: 24129546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of glioma stem-like cells from human glioblastomas.
    Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y
    Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
    Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
    Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer.
    Ayub TH; Keyver-Paik MD; Debald M; Rostamzadeh B; Thiesler T; Schröder L; Barchet W; Abramian A; Kaiser C; Kristiansen G; Kuhn W; Kübler K
    Oncotarget; 2015 Jun; 6(18):16437-48. PubMed ID: 25999351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.
    Zhu X; Prasad S; Gaedicke S; Hettich M; Firat E; Niedermann G
    Oncotarget; 2015 Jan; 6(1):171-84. PubMed ID: 25426558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.